Advancing CAR T cell therapy through the use of multidimensional omics data NatureRevClinOncol nature.com/articles/s4157…

Very honored to publish this review with talented trainees and outstanding collaborators Jingwen Yang Yamei Chen Jing Ying Michael Green, PhD Texas A&M IBT MD Anderson Cancer Center

🥼 This Cancer Cell study by scientists at the @NCIResearchCtr (@theredmanMD, @gulleyj1, Dr. Pat Soon-Shiong & more) and collaborators illustrates the physiological and metabolic changes underlying #Tcell responses to neoadjuvant #immunotherapies. 📘: bit.ly/41PtqUR

Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1 Nature Rev Immunol Honjo nature.com/articles/s4157…

16 databases of scRNAseq datasets. 👇 🧵 Reuse them! #singlecell #bioinformatics

Proud to share our latest work Expanding PROTACtable genome universe of E3 ligases Nature Communications nature.com/articles/s4146… Led by talented Yuan Liu, and another wonderful collaboration with @NCIEytanRuppin! IU Simon Comprehensive Cancer Center IU Biostatistics IUPUI

Systematic discovery of neoepitope–HLA pairs for neoantigens shared among patients and tumor types - Genentech Adaptive Biotech go.nature.com/3M3zoMf

New #JITC article: Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma bit.ly/3S50JSc Jing Ying

Thanks for sharing! This work is led by Chengxuan Chen Yuan Liu

#GUTAbstract by Yu et al on the paper "Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss" via bit.ly/3vGR0IY Paper: bit.ly/4akU3Wz Jing Ying #HBV #HepatitisB

#GUTImages from the paper by Yu et al entitled "Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss" via bit.ly/4akU3Wz Jing Ying #HepatitisB

New #JITC article: Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors bit.ly/4bH8Bj5

Cardiovascular toxicity in antitumor therapy: biological and therapeut... sciencedirect.com/science/articl… Happy to share our latest review Trends in Cancer, led by talented Jing Ying!

Our tool for predicting patient responses to immunotherapy, LORIS, has been featured in a commentary paper by Nature Cancer! Big thanks to the authors for the highlight. #CancerResearch #immunotherapy #ICB #AI shorturl.at/uDGv9

glad to see our group's work on spatial transcriptomics published on Nature Genetics nature.com/articles/s4158…

Thrilled to share our paper published in nature, where we uncover a new process of tumor initiation through a polyclonal-to-monoclonal transition at the @precancerous stage. So proud of my fantastic team (led by Zhaolian Lu ) and incredible collaborators! nature.com/articles/s4158…

Happy to share our latest work published in Cancer Discovery led by Mei Luo Jingwen Yang! Great collaboration with @NCIEytanRuppin Gordon Mills! IU Simon Comprehensive Cancer Center Biostatistics & Health Data Science IUSM iubioinfo

Happy to share our latest work in AD! Led by Chengxuan Chen Yuan Liu and great collaborations with Jungsu Kim @Asaykin Meichen Yu Kwangsik T. Nho Wenbo Li science.org/doi/full/10.11… IU Indianapolis

Happy to share our latest work published in Advanced Science! advanced.onlinelibrary.wiley.com/doi/10.1002/ad…

Ancestral Differences in Anti-Cancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations brnw.ch/21wRpym By Mei Luo, Jingwen Yang, Gordon Mills, @NCIEytanRuppin, and Leng Han OHSU Knight Cancer Institute National Cancer Institute Indiana University IU Simon Comprehensive Cancer Center @IUPUI